** Shares of ReNerve RNV.AX rise 9.5% to A$0.115
** Stock set for its strongest session since March 28, if current trends hold
** The medical devices maker forms a partnership with NetCentrix Ventures to establish and develop operations in the Indian healthcare market
** Co says the Indian nerve repair market currently valued at $115 million, has a growth rate of 18.5% and is expected to nearly double by 2030
** Stock down 34.3% YTD, including current session's moves
(Reporting by Manasi Dasa in Bengaluru)
((Manasi.DasaSundeep@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.